Lowlite Investments, Inc. D/B/A Olympia Pharmacy
Complete recall history across all FDA and CPSC categories, 105 total recalls
Lowlite Investments, Inc. D/B/A Olympia Pharmacy appears in recall records across 1 category. This page consolidates all FDA food, drug, and medical device enforcement actions, plus CPSC consumer product recalls associated with this company. Recall data is sourced from openFDA and CPSC public databases.
Drug Recalls (105)
FDA drug safety enforcement actions by Lowlite Investments, Inc. D/B/A Olympia Pharmacy. Showing most recent 50.
| Date | Product | Reason | Class |
|---|---|---|---|
| May 29, 2013 | Buprenorphine 0.3 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL | Lack of Assurance of Sterility: FDA inspection findings resulted in concerns ... | Class II |
| May 29, 2013 | Voriconazole 5% Ophthalmic drop compounded by Olympia Pharmacy, Orlando, FL | Lack of Assurance of Sterility: FDA inspection findings resulted in concerns ... | Class II |
| May 29, 2013 | Vitamin B-Buildup Injection, compounded by Olympia Pharmacy, Orlando, FL | Lack of Assurance of Sterility: FDA inspection findings resulted in concerns ... | Class II |
| May 29, 2013 | MICC (Methionine, Inositol, Choline, Cyanocobalamin, Chromium) Inj and MICC 2... | Lack of Assurance of Sterility: FDA inspection findings resulted in concerns ... | Class II |
| May 29, 2013 | Lisinopril 20 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL | Lack of Assurance of Sterility: FDA inspection findings resulted in concerns ... | Class II |
| May 29, 2013 | Atipamezole 10 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL | Lack of Assurance of Sterility: FDA inspection findings resulted in concerns ... | Class II |
| May 29, 2013 | Ketoprofen Solution 10% Injection, compounded by Olympia Pharmacy, Orlando, FL | Lack of Assurance of Sterility: FDA inspection findings resulted in concerns ... | Class II |
| May 29, 2013 | Amikacin Sulfate 250 mg/ml Injection, compounded by Olympia Pharmacy, Orlando... | Lack of Assurance of Sterility: FDA inspection findings resulted in concerns ... | Class II |
| May 29, 2013 | Polidocanol (0.75%, 1%, 3%, and 10%) Injection, compounded by Olympia Pharmac... | Lack of Assurance of Sterility: FDA inspection findings resulted in concerns ... | Class II |
| May 29, 2013 | Taurine 100 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL | Lack of Assurance of Sterility: FDA inspection findings resulted in concerns ... | Class II |
| May 29, 2013 | Ceftiofur GM vial 50 mg/ml Injection, compounded by Olympia Pharmacy, Orlando... | Lack of Assurance of Sterility: FDA inspection findings resulted in concerns ... | Class II |
| May 29, 2013 | PEN-DEX-CHLOR Injection, compounded by Olympia Pharmacy, Orlando, FL | Lack of Assurance of Sterility: FDA inspection findings resulted in concerns ... | Class II |
| May 29, 2013 | Methylcobalamin 1 mg/ml / Folic Acid 2.5 mg/ml Injection, compounded by Olymp... | Lack of Assurance of Sterility: FDA inspection findings resulted in concerns ... | Class II |
| May 29, 2013 | Estradiol Cypionate 2 mg/ml Test Cyp 50 mg/ml Injection, compounded by Olympi... | Lack of Assurance of Sterility: FDA inspection findings resulted in concerns ... | Class II |
| May 29, 2013 | Meloxicam 5 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL | Lack of Assurance of Sterility: FDA inspection findings resulted in concerns ... | Class II |
| May 29, 2013 | Chlorpromazine HCL 100 mg/ml Injection, compounded by Olympia Pharmacy, Orlan... | Lack of Assurance of Sterility: FDA inspection findings resulted in concerns ... | Class II |
| May 29, 2013 | Potassium Phosphate Injection, compounded by Olympia Pharmacy, Orlando, FL | Lack of Assurance of Sterility: FDA inspection findings resulted in concerns ... | Class II |
| May 29, 2013 | Doxapram 20 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL | Lack of Assurance of Sterility: FDA inspection findings resulted in concerns ... | Class II |
| May 29, 2013 | Gentamicin 80 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL | Lack of Assurance of Sterility: FDA inspection findings resulted in concerns ... | Class II |
| May 29, 2013 | Sodium Salicylate 40% Injection, compounded by Olympia Pharmacy, Orlando, FL | Lack of Assurance of Sterility: FDA inspection findings resulted in concerns ... | Class II |
| May 29, 2013 | Disodium EDTA Injection, compounded by Olympia Pharmacy, Orlando, FL | Lack of Assurance of Sterility: FDA inspection findings resulted in concerns ... | Class II |
| May 29, 2013 | Miconazole 3% Injection, compounded by Olympia Pharmacy, Orlando, FL | Lack of Assurance of Sterility: FDA inspection findings resulted in concerns ... | Class II |
| May 29, 2013 | Betamethasone Phosphate/Acetate 6 mg/ml Injection, compounded by Olympia Phar... | Lack of Assurance of Sterility: FDA inspection findings resulted in concerns ... | Class II |
| May 29, 2013 | Naproxen 100 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL | Lack of Assurance of Sterility: FDA inspection findings resulted in concerns ... | Class II |
| May 29, 2013 | Vitamin 15 (HEMO15) Injection, compounded by Olympia Pharmacy, Orlando, FL | Lack of Assurance of Sterility: FDA inspection findings resulted in concerns ... | Class II |
| May 29, 2013 | Vitamin B12 Cyanocobalamin 5000 mcg Injection, compounded by Olympia Pharmacy... | Lack of Assurance of Sterility: FDA inspection findings resulted in concerns ... | Class II |
| May 29, 2013 | Betamethasone Sodium Phosphate 12 mg/ml Injection, compounded by Olympia Phar... | Lack of Assurance of Sterility: FDA inspection findings resulted in concerns ... | Class II |
| May 29, 2013 | Alprostadil 2000 mcg/ml, compounded by Olympia Pharmacy, Orlando, FL | Lack of Assurance of Sterility: FDA inspection findings resulted in concerns ... | Class II |
| May 29, 2013 | HACC 270.1 Injection, compounded by Olympia Pharmacy, Orlando, FL | Lack of Assurance of Sterility: FDA inspection findings resulted in concerns ... | Class II |
| May 29, 2013 | Beta Alanine 100 mg/ml / l-carnosine 100 mg/ml Injection, compounded by Olymp... | Lack of Assurance of Sterility: FDA inspection findings resulted in concerns ... | Class II |
| May 29, 2013 | Dexamethasone Sodium Phosphate 6 mg/ml Injection, compounded by Olympia Pharm... | Lack of Assurance of Sterility: FDA inspection findings resulted in concerns ... | Class II |
| May 29, 2013 | Iodine 20 mg Injection, compounded by Olympia Pharmacy, Orlando, FL | Lack of Assurance of Sterility: FDA inspection findings resulted in concerns ... | Class II |
| May 29, 2013 | BNP/Dexamethasone Eye Ointment, compounded by Olympia Pharmacy, Orlando, FL | Lack of Assurance of Sterility: FDA inspection findings resulted in concerns ... | Class II |
| May 29, 2013 | Aminophylline 2.5% Injection, compounded by Olympia Pharmacy, Orlando, FL | Lack of Assurance of Sterility: FDA inspection findings resulted in concerns ... | Class II |
| May 29, 2013 | Clenbuterol 0.03mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL | Lack of Assurance of Sterility: FDA inspection findings resulted in concerns ... | Class II |
| May 29, 2013 | Sodium Tetradecyl Sulfate (0.125%, 1%, 2.5%, 3%, and 4%) Injection, compounde... | Lack of Assurance of Sterility: FDA inspection findings resulted in concerns ... | Class II |
| May 29, 2013 | Furosemide 50 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL | Lack of Assurance of Sterility: FDA inspection findings resulted in concerns ... | Class II |
| May 29, 2013 | L-ArGiNINE 200 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL | Lack of Assurance of Sterility: FDA inspection findings resulted in concerns ... | Class II |
| May 29, 2013 | Gentamicin 0.3% Injection, compounded by Olympia Pharmacy, Orlando, FL | Lack of Assurance of Sterility: FDA inspection findings resulted in concerns ... | Class II |
| May 29, 2013 | Caco/Copper 6. 2 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL | Lack of Assurance of Sterility: FDA inspection findings resulted in concerns ... | Class II |
| May 29, 2013 | Deslorelin 15 mg vial, compounded by Olympia Pharmacy, Orlando, FL | Lack of Assurance of Sterility: FDA inspection findings resulted in concerns ... | Class II |
| May 29, 2013 | Aminocaproic Acid 0.5mg/ml Injection,compounded by Olympia Pharmacy, Orlando, FL | Lack of Assurance of Sterility: FDA inspection findings resulted in concerns ... | Class II |
| May 29, 2013 | Methylcobalamin P 10/ml Creatine 40 mg/ml / Arginine 100 mg/ml Injection, com... | Lack of Assurance of Sterility: FDA inspection findings resulted in concerns ... | Class II |
| May 29, 2013 | Papaverine 40 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL | Lack of Assurance of Sterility: FDA inspection findings resulted in concerns ... | Class II |
| May 29, 2013 | Pentosan 250 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL | Lack of Assurance of Sterility: FDA inspection findings resulted in concerns ... | Class II |
| May 29, 2013 | Detomidine w/Xylazine 100 mg/mg Injection, compounded by Olympia Pharmacy, Or... | Lack of Assurance of Sterility: FDA inspection findings resulted in concerns ... | Class II |
| May 29, 2013 | Quadmix, compounded by Olympia Pharmacy, Orlando, FL | Lack of Assurance of Sterility: FDA inspection findings resulted in concerns ... | Class II |
| May 29, 2013 | Tripelennamine 20 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL | Lack of Assurance of Sterility: FDA inspection findings resulted in concerns ... | Class II |
| May 29, 2013 | Tacrolimus (0.02% and 0.03%) drops, compounded by Olympia Pharmacy, Orlando, FL | Lack of Assurance of Sterility: FDA inspection findings resulted in concerns ... | Class II |
| May 29, 2013 | Medetomidine 2 mg/ml Injection, compounded by Olympia Pharmacy, Orlando, FL | Lack of Assurance of Sterility: FDA inspection findings resulted in concerns ... | Class II |
Frequently Asked Questions
A high number of recalls does not necessarily indicate that a company is unsafe. Large manufacturers that produce thousands of products across multiple categories will statistically appear in recall databases more frequently. What matters more is the severity of each recall (Class I being the most serious), the speed of response, and whether the company proactively identified and addressed the issue. Companies with robust safety programs often catch problems earlier.
Food, drug, and medical device recall data comes from the FDA's openFDA enforcement database, which contains all FDA enforcement reports. Consumer product recall data comes from the U.S. Consumer Product Safety Commission (CPSC). Both sources are public government databases that are updated regularly. RecallCheck aggregates these sources to provide a unified view of a company's recall history.
The FDA classifies recalls into three categories. Class I is the most serious, there is a reasonable probability that use of or exposure to the product will cause serious adverse health consequences or death. Class II means the product may cause temporary or medically reversible health problems, or the probability of serious consequences is remote. Class III is the least serious, the product is unlikely to cause adverse health consequences. CPSC product recalls do not use this classification system.
Yes. You can search for any company using the firm/manufacturer pages for each category: Food Firms, Drug Firms, Device Firms, or Product Manufacturers. You can also use the search functionality on any browse page to find recalls by company name.
Explore More Recalls
Search recalls by category, state, reason, or firm across all our databases.